Deletion of putative intronic control sequences does not alter cell or stage specific expression of Cr2

Molecular Immunology

Volumn 47, Issue 2-3, 2009, Pages 517-525

  Roundy, Kirstin M ^a   Weis, Janis J ^a   Weis, John H ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Activation; Complement receptor; T cells; Transcription

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; OCTAMER TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR YY1;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BINDING SITE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; INTRON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CELL DEATH; DENDRITIC CELLS, FOLLICULAR; FLOW CYTOMETRY; INTRONS; MICE; MICE, INBRED STRAINS; ORGAN SPECIFICITY; RECEPTORS, COMPLEMENT 3D; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE DELETION; T-LYMPHOCYTES;

MUS;

EID: 70450224885     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.08.016     Document Type: Article

References (41)

1. Allen C.D., and Cyster J.G. Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. Semin. Immunol. 20 (2008) 14-25
2. Boackle S.A., Culhane K.K., Brown J.M., Haas M., Bao L., Quigg R.J., and Holers V.M. CR1/CR2 deficiency alters IgG3 autoantibody production and IgA glomerular deposition in the MRL/lpr model of SLE. Autoimmunity 37 (2004) 111-123
3. de Laat W., Klous P., Kooren J., Noordermeer D., Palstra R.J., Simonis M., Splinter E., and Grosveld F. Three-dimensional organization of gene expression in erythroid cells. Curr. Top. Dev. Biol. 82 (2008) 117-139
4. Debnath I., Roundy K.M., Weis J.J., and Weis J.H. Defining in vivo transcription factor complexes of the murine CD21 and CD23 genes. J. Immunol. 178 (2007) 7139-7150
5. Dekker J. The three 'C' s of chromosome conformation capture: controls, controls, controls. Nat. Methods 3 (2006) 17-21
6. Dekker J., Rippe K., Dekker M., and Kleckner N. Capturing chromosome conformation. Science 295 (2002) 1306-1311
7. Delibrias C.C., Kazatchkine M.D., and Fischer E. Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. Scand. J. Immunol. 38 (1993) 183-189
8. Fischer E., Delibrias C., and Kazatchkine M.D. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol. 146 (1991) 865-869
9. Fischer E.M., Mouhoub A., Maillet F., Fremeaux-Bacchi V., Krief C., Gould H., Berrih-Aknin S., and Kazatchkine M.D. Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes. Int. Immunol. 11 (1999) 1841-1849
10. Haas K.M., Hasegawa M., Steeber D.A., Poe J.C., Zabel M.D., Bock C.B., Karp D.R., Briles D.E., Weis J.H., and Tedder T.F. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 17 (2002) 713-723
11. Hojgaard A., Close R., Dunn D.M., Weiss R.B., Weis J.J., and Weis J.H. Altered localization of CXCL13 expressing cells in mice deficient in Pactolus following an inflammatory stimulus. Immunology 119 (2006) 212-223
12. Hu H., Martin B.K., Weis J.J., and Weis J.H. Expression of the murine CD21 gene is regulated by promoter and intronic sequences. J. Immunol. 158 (1997) 4758-4768
13. Huber C., Thielen C., Seeger H., Schwarz P., Montrasio F., Wilson M.R., Heinen E., Fu Y.X., Miele G., and Aguzzi A. Lymphotoxin-beta receptor-dependent genes in lymph node and follicular dendritic cell transcriptomes. J. Immunol. 174 (2005) 5526-5536
14. Jacobson A.C., and Weis J.H. Comparative functional evolution of human and mouse CR1 and CR2. J. Immunol. 181 (2008) 2953-2959
15. Kaya Z., Afanasyeva M., Wang Y., Dohmen K.M., Schlichting J., Tretter T., Fairweather D., Holers V.M., and Rose N.R. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat. Immunol. 2 (2001) 739-745
16. Kaya Z., Tretter T., Schlichting J., Leuschner F., Afanasyeva M., Katus H.A., and Rose N.R. Complement receptors regulate lipopolysaccharide-induced T-cell stimulation. Immunology 114 (2005) 493-498
17. Kosco M.H., Pflugfelder E., and Gray D. Follicular dendritic cell-dependent adhesion and proliferation of B cells in vitro. J. Immunol. 148 (1992) 2331-2339
18. Kranich J., Krautler N.J., Heinen E., Polymenidou M., Bridel C., Schildknecht A., Huber C., Kosco-Vilbois M.H., Zinkernagel R., Miele G., and Aguzzi A. Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8. J. Exp. Med. 205 (2008) 1293-1302
19. Kurtz C.B., O'Toole E., Christensen S.M., and Weis J.H. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144 (1990) 3581-3591
20. Liu Z., and Garrard W.T. Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3′ boundary sequence spanning 46 kilobases. Mol. Cell. Biol. 25 (2005) 3220-3231
21. Makar K.W., Pham C.T., Dehoff M.H., O'Connor S.M., Jacobi S.M., and Holers V.M. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene. J. Immunol. 160 (1998) 1268-1278
22. Makar K.W., Ulgiati D., Hagman J., and Holers V.M. A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation. Int. Immunol. 13 (2001) 657-664
23. Morrison T.B., Ma Y., Weis J.H., and Weis J.J. Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J. Clin. Microbiol. 37 (1999) 987-992
24. Murphy K.M., Heimberger A.B., and Loh D.Y. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250 (1990) 1720-1723
25. Murrell A., Heeson S., and Reik W. Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat. Genet. 36 (2004) 889-893
26. Pratt J.R., Basheer S.A., and Sacks S.H. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat. Med. 8 (2002) 582-587
27. Qian Z., Bieler J.G., Baldwin W.M., and Wasowska B.A. Expression of CR1/2 receptor on alloantigen-stimulated mouse T cells. Transplant. Proc. 37 (2005) 32-34
28. Qin D., Wu J., Carroll M.C., Burton G.F., Szakal A.K., and Tew J.G. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses. J. Immunol. 161 (1998) 4549-4554
29. Rayhel E.J., Dehoff M.H., and Holers V.M. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins. J. Immunol. 146 (1991) 2021-2026
30. Reynes M., Aubert J.P., Cohen J.H., Audouin J., Tricottet V., Diebold J., and Kazatchkine M.D. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J. Immunol. 135 (1985) 2687-2694
31. Rieux-Laucat F., Le Deist F., and Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ. 10 (2003) 124-133
32. Roundy K., Kollhoff A., Eichwald E.J., Weis J.J., and Weis J.H. Microphthalmic mice display a B cell deficiency similar to that seen for mast and NK cells. J. Immunol. 163 (1999) 6671-6678
33. Spilianakis C.G., Lalioti M.D., Town T., Lee G.R., and Flavell R.A. Interchromosomal associations between alternatively expressed loci. Nature 435 (2005) 637-645
34. Sukumar S., Conrad D.H., Szakal A.K., and Tew J.G. Differential T cell-mediated regulation of CD23 (Fc epsilonRII) in B cells and follicular dendritic cells. J. Immunol. 176 (2006) 4811-4817
35. Tedder T.F., Clement L.T., and Cooper M.D. Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J. Immunol. 133 (1984) 678-683
36. Tolnay M., Lambris J.D., and Tsokos G.C. Transcriptional regulation of the complement receptor 2 gene: role of a heterogeneous nuclear ribonucleoprotein. J. Immunol. 159 (1997) 5492-5501
37. Tsoukas C.D., and Lambris J.D. Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur. J. Immunol. 18 (1988) 1299-1302
38. Zabel M.D., Byrne B.L., Weis J.J., and Weis J.H. Cell-specific expression of the murine CD21 gene depends on accessibility of promoter and intronic elements. J. Immunol. 165 (2000) 4437-4445
39. Zabel M.D., and Weis J.H. Cell-specific regulation of the CD21 gene. Int. Immunopharmacol. 1 (2001) 483-493
40. Zabel M.D., Weis J.J., and Weis J.H. Lymphoid transcription of the murine CD21 gene is positively regulated by histone acetylation. J. Immunol. 163 (1999) 2697-2703
41. Zabel M.D., Wheeler W., Weis J.J., and Weis J.H. Yin Yang 1, Oct1, and NFAT-4 form repeating, cyclosporin-sensitive regulatory modules within the murine CD21 intronic control region. J. Immunol. 168 (2002) 3341-3350